David Skaar

At the forefront of innovation in the field of toxicology, Dr. David Skaar serves as an Associate Research Professor in the Toxicology Program at North Carolina State University. With a robust academic background, he earned his Ph.D. from Duke University and a Bachelor of Science from the New Mexico Institute of Mining and Technology. Dr. Skaar's research is primarily centered on the intricate world of epigenetics, with a particular focus on DNA methylation and its implications in various diseases. Dr. Skaar's work is pivotal in understanding how epigenetic modifications can influence disease development and progression. His research aims to unravel the complexities of DNA methylation patterns and their potential as biomarkers for disease diagnosis and prognosis. By exploring these molecular mechanisms, Dr. Skaar contributes significantly to the advancement of the Toxicology Program at NC State, fostering a deeper understanding of how environmental factors can impact genetic expression and health outcomes. In addition to his research endeavors, Dr. Skaar is dedicated to mentoring the next generation of scientists, guiding students through the intricacies of toxicology and epigenetics. His commitment to education and research excellence makes him a valuable asset to the academic community, continually pushing the boundaries of knowledge in his field. Through his work, Dr. Skaar not only enhances the scientific community's understanding of epigenetic processes but also contributes to the development of innovative approaches to disease prevention and treatment.